Spinogenix, the company behind the once-a-day pill that restored lost nerve cell connections in people with amyotrophic ...

A group of eight molecules in the blood can be used as a biomarker to distinguish ALS from other neurodegenerative conditions ...

Mayo Clinic researchers have just been awarded a new federal grant to start an investigation of an experimental drug on ...

Mayo Clinic researchers have just been awarded a new federal grant to start an investigation of an experimental drug on ...

Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is the most common degenerative motor neuron disease ...

A blood test has been shown to accurately identify patients with amyotrophic lateral sclerosis at early stages, which could ...

Direct-to-participant study to reach 150 people living with ALS, with 2 participants already enrolled.

Mayo Clinic in Florida has received a grant from the National Institute of Neurological Disorders and Stroke (NIDS) to begin an innovative study that will provide hundreds of patients with amyotrophic ...

A highly accurate diagnostic blood test has been developed for amyotrophic lateral sclerosis (ALS), a progressive ...

Schlieren, Zurich/Switzerland, September 24, 2024 - Mabylon AG, a leader in the high-throughput discovery, characterization, and development of human-derived antibodies, today announced that it has ...

(Lawrenceburg, IN) – The 8th annual Cruisin’ to a Cure for ALS (Amyotrophic Lateral Sclerosis) car show in Lawrenceburg set ...

About Rozebalamin (generic name: mecobalamin, development code: E0302) ...